Arkolith/Insider Trading/EW/Form 4

Zovighian Bernard J

CEO, DirectorEdwards Lifesciences Corp (EW) · full profile →Form 4 · filed May 12, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$2.8M
Net Open-Market Flow
-$2.8M
Transactions
7
6 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 12, 2026Gift(G)27K—$048K
May 12, 2026Gift(G)27K—$099K
May 12, 2026Sell(S)845$78.40$66K48K
May 12, 2026Sell(S)36K$77.92$2.8M12K
May 11, 2026Tax withholding(F)26K$79.96$2.1M126K
May 11, 2026Option exercise(M)47K—$0157K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 11, 2026Option exercise(M)47K—$00

Transaction Codes

G
Gift
S
Open-market sale
F
Shares withheld for taxes
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001225208-26-005172) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML